138 related articles for article (PubMed ID: 28956425)
1. Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.
Majewski K; Agier J; Kozłowska E; Brzezińska-Błaszczyk E
J Biol Regul Homeost Agents; 2017; 31(3):731-736. PubMed ID: 28956425
[TBL] [Abstract][Full Text] [Related]
2. Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.
Majewski K; Żelechowska P; Brzezińska-Błaszczyk E
Clin Invest Med; 2017 Feb; 40(1):E34-E39. PubMed ID: 28218580
[TBL] [Abstract][Full Text] [Related]
3. Status of cathelicidin IL-37, cytokine TNF, and vitamin D in patients with pulmonary tuberculosis.
Majewski K; Agier J; Kozłowska E; Brzezińska-Błaszczyk E
J Biol Regul Homeost Agents; 2018; 32(2):321-325. PubMed ID: 29685013
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
Majewski K; Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E
Cent Eur J Immunol; 2018; 43(4):453-457. PubMed ID: 30799994
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of peptide cathelicidin LL-37 in elderly patients with depression.
Kozłowska E; Wysokiński A; Brzezińska-Błaszczyk E
Psychiatry Res; 2017 Sep; 255():156-160. PubMed ID: 28550757
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis.
Yamshchikov AV; Kurbatova EV; Kumari M; Blumberg HM; Ziegler TR; Ray SM; Tangpricha V
Am J Clin Nutr; 2010 Sep; 92(3):603-11. PubMed ID: 20610636
[TBL] [Abstract][Full Text] [Related]
7. Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis.
Acen EL; Biraro IA; Worodria W; Joloba ML; Nkeeto B; Musaazi J; Kateete DP
PLoS One; 2021; 16(6):e0252762. PubMed ID: 34115790
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D₃ Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis.
Ashenafi S; Mazurek J; Rehn A; Lemma B; Aderaye G; Bekele A; Assefa G; Chanyalew M; Aseffa A; Andersson J; Bergman P; Brighenti S
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29867045
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis.
Cakir E; Torun E; Gedik AH; Umutoglu T; Aktas EC; Topuz U; Deniz G
Int J Tuberc Lung Dis; 2014 Jun; 18(6):671-5. PubMed ID: 24903937
[TBL] [Abstract][Full Text] [Related]
10. Status of vitamin D and the associated host factors in pulmonary tuberculosis patients and their household contacts: A cross sectional study.
Panda S; Tiwari A; Luthra K; Sharma SK; Singh A
J Steroid Biochem Mol Biol; 2019 Oct; 193():105419. PubMed ID: 31255688
[TBL] [Abstract][Full Text] [Related]
11. Human cathelicidin LL-37 - Does it influence the homeostatic imbalance in mental disorders?
Kozlowska E; Wysokinski A; Majewski K; Agier J; Margulska A; Brzezinska-Blaszczyk E
J Biosci; 2018 Jun; 43(2):321-327. PubMed ID: 29872020
[TBL] [Abstract][Full Text] [Related]
12. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.
Babikir IH; Abugroun EA; Bilal NE; Alghasham AA; Abdalla EE; Adam I
BMC Infect Dis; 2018 Jan; 18(1):17. PubMed ID: 29310594
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
[TBL] [Abstract][Full Text] [Related]
14. Circulating cathelicidin LL-37 level is increased in euthymic patients with bipolar disorder.
Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E; Margulska A; Wysokiński A
J Clin Neurosci; 2018 Feb; 48():168-172. PubMed ID: 29239826
[TBL] [Abstract][Full Text] [Related]
15. A comparison of vitamin D and cathelicidin (LL-37) levels between patients with active TB and their healthy contacts in a high HIV prevalence setting: a prospective descriptive study.
Lungu PS; Kilembe W; Lakhi S; Sukwa T; Njelesani E; Zumla AI; Mwaba P
Trans R Soc Trop Med Hyg; 2022 Apr; 116(4):336-343. PubMed ID: 34401915
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin (LL-37) and human β2-defensin levels of children with post-infectious bronchiolitis obliterans.
Gedik AH; Cakir E; Gokdemir Y; Uyan ZS; Kocyigit A; Torun E; Karadag B; Ersu R; Karakoc F
Clin Respir J; 2017 Mar; 11(2):243-247. PubMed ID: 26073571
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Antibacterial Effect of Cationic Peptide LL-37 and Cefalexin on Clinical Staphylococcus aureus-induced Infection after Femur Fracture Fixation.
Yan CY; Liu YZ; Xu ZH; Yang HY; Li J
Orthop Surg; 2020 Aug; 12(4):1313-1318. PubMed ID: 32725811
[TBL] [Abstract][Full Text] [Related]
18. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
[TBL] [Abstract][Full Text] [Related]
19. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis.
Türkoğlu O; Emingil G; Kütükçüler N; Atilla G
J Periodontol; 2009 Jun; 80(6):969-76. PubMed ID: 19485828
[TBL] [Abstract][Full Text] [Related]
20. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.
Dixon BM; Barker T; McKinnon T; Cuomo J; Frei B; Borregaard N; Gombart AF
BMC Res Notes; 2012 Oct; 5():575. PubMed ID: 23095332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
